Recombinant mouse IL-21 R protein

Cat No.
ATGP4056

Size

QTY

List Price

10ug

USD 120


20ug

USD 220

50ug

USD 290

100ug

USD 480

250ug

USD 850

500ug

USD 1,450

1mg

USD 2,420

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
HEK293
Domain
20-237aa
UniProt No.
Q9JHX3
NCBI Accession No.
NP_068687.1
Alternative names
Interleukin-21 receptor, IL-21 receptor, IL-21R, Il21r, Lymphocyte receptor beta, LR-beta, Novel interleukin receptor, Novel cytokine receptor 8, NR8, Novel interleukin receptor, CD360, CD360 antigen, NILR, Nilr

Product Specification

Molecular Weight
52kDa (457aa)
Concentration
1mg/ml (determined by Absorbance at 280nm)
Formulation
Liquid. In Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 95% by SDS - PAGE
Bioactivity
Measured by its ability to inhibit IFN-g secretion using NK-92 human natural killer cells. The ED50 range ≤ 4 ug/ml with mouse IL-2(CAT# ATGP4049).
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
hIgG-His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

Mouse IL-21R in inhibit the IFN-g secretion of the NK-92 human natural killer cells in the presence of mouse IL-21(CAT# ATGP4049). The ED50 range ≤ 4 ug/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.